Aptevo Therapeutics Inc.
APVO | NASDAQ
$1.84
$0 (0.00%)
At close: Sep 21, 2026, 3:59 PM ET
$1.88
+$0.04 (+2.28%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -26.41M | -26.26M | -25.97M | -26.47M | -24.03M | -23.7M | -24.13M | -23.72M | -24.95M | -27.02M | -17.41M | -16.15M | -17.46M | 18.5M | 8.03M | 6.07M | 6.64M | -29.3M | -28.86M | -29.32M | -29.03M | -27.9M |
Depreciation & Amortization | 197K | 214K | 240K | 230K | 265K | 307K | 352K | 397K | 436K | 495K | 567K | 612K | 711K | 837K | 901K | 1M | 1.07M | 1.1M | 1.15M | 1.13M | 1.14M | 1.15M |
Stock-Based Compensation | 194K | -27K | 96K | 22K | 94K | 530K | 1.07M | 1.5M | 1.81M | 2M | 2.19M | 2.19M | 2.1M | 2.12M | 1.8M | 1.62M | 1.58M | 1.67M | 1.64M | 1.66M | 1.69M | 1.42M |
Other Working Capital | -2.39M | -1.58M | -893K | 373K | -456K | -1.3M | -59K | -502K | -93K | 1.08M | 1.7M | 1.59M | 1.33M | 1.99M | 1.37M | 2.19M | 1.49M | 104K | 555K | -563K | 24.04M | 25.19M |
Other Non-Cash Items | 1.62M | 1.09M | 1.09M | n/a | n/a | 273K | n/a | n/a | 778K | 778K | 788K | 812K | 6K | -35.57M | -33.9M | -31.16M | -28.7M | 8.93M | 7.54M | 6.81M | 4.85M | 2.79M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -778K | -778K | -778K | -778K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -943K | -2M | -1.05M | 106K | -983K | -1.12M | -1.08M | -1.45M | -1.59M | 1.58M | 2.91M | 896K | 1.58M | 2.78M | 2.14M | 3.68M | 2.6M | -1.19M | -2.66M | -3.89M | -4.71M | -3.1M |
Operating Cash Flow | -25.34M | -26.98M | -25.59M | -26.12M | -24.65M | -23.71M | -23.79M | -23.28M | -24.3M | -22.95M | -11.73M | -12.42M | -13.07M | -11.34M | -21.02M | -18.96M | -17.31M | -19.29M | -21.68M | -23.92M | -26.07M | -25.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -29K | -29K | -147K | -156K | -522K | -713K | -683K | -670K | -279K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.12M | 28.12M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -29K | -29K | -147K | -156K | -522K | -713K | -683K | 27.45M | 27.84M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.47M | -3.97M | -4.47M | -4.97M | -12.27M | 19.04M | 3.46M | 3.96M | 4.17M | -26.63M | -10.55M | -10.55M |
Common Stock Repurchased | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11K | -11K | -11K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 557K | 556K | 557K | 5.56M | 5.56M | 5.56M | 5.56M | -104K | 3.04M | 3.04M | 3.04M | 3.14M | -8K | -3.12M | 2.72M | -31.18M | -18.21M | -6.78M | 21.88M | 77.04M | 88.8M | 80.48M |
Financial Cash Flow | 25.73M | 39.37M | 38.5M | 39.42M | 25.99M | 15.6M | 15.6M | 11.92M | 11.36M | 7.87M | 6M | 8.95M | 4.11M | 447K | -2.62M | -11.69M | -14.21M | -2.72M | 26.16M | 50.49M | 78.24M | 69.92M |
Net Cash Flow | 387K | 12.39M | 12.91M | 13.31M | 1.34M | -8.11M | -8.19M | -11.36M | -12.94M | -15.08M | -5.73M | -3.47M | -8.97M | -10.92M | -23.67M | -30.8M | -31.68M | -22.53M | 3.77M | 25.88M | 51.5M | 45.83M |
Free Cash Flow | -25.34M | -26.98M | -25.59M | -26.12M | -24.65M | -23.71M | -23.79M | -23.28M | -24.3M | -22.95M | -11.73M | -12.42M | -13.08M | -11.37M | -21.05M | -19.11M | -17.47M | -19.81M | -22.39M | -24.61M | -26.74M | -25.93M |
Adj. Free Cash Flow | -25.54M | -26.96M | -25.69M | -26.14M | -24.74M | -24.24M | -24.85M | -24.78M | -26.1M | -24.94M | -13.92M | -14.61M | -15.17M | -13.48M | -22.85M | -20.73M | -19.05M | -21.48M | -24.04M | -26.27M | -28.42M | -27.34M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -29K | -29K | -29K | -25K | n/a | n/a | -88K | -88K | -88K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -118K | -131K | -522K | -713K | -595K | -582K | -191K |
Owner Earnings | -25.34M | -26.98M | -25.59M | -26.12M | -24.65M | -23.71M | -23.79M | -23.28M | -24.3M | -22.95M | -11.73M | -12.42M | -13.08M | -11.37M | -21.05M | -18.99M | -17.33M | -19.29M | -21.68M | -24.01M | -26.16M | -25.74M |
Add to Watchlist
Select watchlists to add or remove APVO